NICE recommends wider use of Biogen MS drug via NHS NICE has backed NHS use of natalizumab, a key treatment option that is safe for use in pregnancy, for more patients with multiple sclerosis.

#neurology #NICE #Biogen #natalizumab #Tysabri #multiplesclerosis #MS #activerelapsingremittingmultiplesclerosis #biosimilar #NICEdraftguidance #Sandoz #PolpharmaBiologics #biosimilarequivalent #Tyruko #activerelapsingremittingMS #rapidlyevolvingsevereMS #biosimilarmedicines
zurl.co/tsiGu

#biosimilars #PolpharmaBiologics #MSPharma #gastroenterology #neurology #dermatology #MENA #vedolizumab #ocrelizumab #guselkumab #ulcerativecolitis #Crohnsdisease #multiplesclerosis #plaquepsoriasis #psoriaticarthritis #biosimilarmanufacturing #MS #PolpharmaBiologicsGroup
zurl.co/GJnQQ